The previous study consistently revealed that diffuse large B-cell lymphoma resistant to treatment exhibited an enhanced FOXO4 expression and stem cell-like properties, reflecting a significant association between the expression of FOXO4 in DLBC and a poor prognosis [23]. Here, FOXO4 is linked to diffuse large B-cell lymphoma.